Trial intelligence / Profile preview

Levocetirizine and diphenhydramine effects on cognitive and psychomotor performance during simulated diving

NL-OMON35024Phase 4Withdrawn

Sponsor
Utrecht University
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of levocetirizine and diphenhydramine in allergic rhinitis (AR) (3 arms), sponsored by Utrecht University. Primary endpoint: Reaction time. Planned start Apr 2010; status: withdrawn.

02

Drugs

levocetirizinediphenhydramine
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NL-OMON35024.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON35024.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call